Qingdao Baheal Medical Inc
SZSE:301015
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Qingdao Baheal Medical Inc
Total Equity
Qingdao Baheal Medical Inc
Total Equity Peer Comparison
1099
601607
600998
000963
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Total Equity
¥2.7B
|
CAGR 3-Years
22%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Total Equity
¥69.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Total Equity
¥68.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Total Equity
¥24B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Total Equity
¥15.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
22%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Total Equity
¥21B
|
CAGR 3-Years
11%
|
CAGR 5-Years
14%
|
CAGR 10-Years
22%
|
See Also
What is Qingdao Baheal Medical Inc's Total Equity?
Total Equity
2.7B
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Total Equity amounts to 2.7B CNY.
What is Qingdao Baheal Medical Inc's Total Equity growth rate?
Total Equity CAGR 5Y
20%
Over the last year, the Total Equity growth was 16%. The average annual Total Equity growth rates for Qingdao Baheal Medical Inc have been 22% over the past three years , 20% over the past five years .
You don't have any saved screeners yet
